Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more

Location: RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT, BELGIUM, 1435, Mont-Saint-Guibert, 1435, USA | Website: https://www.nyxoah.com | Industry: MEDICAL INSTRUMENTS & SUPPLIES | Sector: HEALTHCARE


Market Cap

206M

52 Wk Range

$4.34 - $11.87

Previous Close

$4.59

Open

$4.68

Volume

9,954

Day Range

$4.60 - $4.72

Enterprise Value

194.7M

Cash

10.87M

Avg Qtr Burn

-20.49M

Insider Ownership

37.58%

Institutional Own.

22.23%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date